Finally, treatment every other day of both mouse models with the 3 mg/kg dose of GNE-0723 for five weeks improved the cognitive performance of the J20 mouse model of Alzheimer’s disease in the Morris water maze task and the Scn1-KI mouse model in a contextual fear conditioning task [12]. Here, SCN1A is linked to early-onset autosomal dominant Alzheimer disease.